This is a preview of subscription content, log in via an institution to check access.
Notes
International Society of Pharmacoeconomics and Outcomes Research (ISPOR) Consolidated Health Economic Evaluation Reporting Standards (CHEERS)
US dollars
Reference
Stawowczyk E, et al. A Systematic Review of the Cost-Effectiveness of Biologics for Ulcerative Colitis. PharmacoEconomics : 19 Dec 2017
Rights and permissions
About this article
Cite this article
Biologicals not cost effective for ulcerative colitis. PharmacoEcon Outcomes News 794, 7 (2018). https://doi.org/10.1007/s40274-018-4605-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-018-4605-z